The deal, terms of which were not released, will expand Raleigh, N.C.-based INC Research?s footprint in Australia, New Zealand and India. Clinical-research organizations, or CROs, such as INC Research, Trident and Kendle operate clinical trials for pharmaceutical and biotechnology companies trying to get products approved for the...
Friday, June 3, 2011
New Kendle owner makes another buy
INC Research, which is buying downtown-based Kendle International Inc. (NASDAQ: KNDL), announced that it?s also acquired the Australian company Trident Clinical Research.
The deal, terms of which were not released, will expand Raleigh, N.C.-based INC Research?s footprint in Australia, New Zealand and India. Clinical-research organizations, or CROs, such as INC Research, Trident and Kendle operate clinical trials for pharmaceutical and biotechnology companies trying to get products approved for the... 
The deal, terms of which were not released, will expand Raleigh, N.C.-based INC Research?s footprint in Australia, New Zealand and India. Clinical-research organizations, or CROs, such as INC Research, Trident and Kendle operate clinical trials for pharmaceutical and biotechnology companies trying to get products approved for the...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment